Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

BALAXI PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 583.51-91.805.4623.93404.51

What is the latest EBIT Growth ratio of BALAXI PHARMACEUTICALS ?

The latest EBIT Growth ratio of BALAXI PHARMACEUTICALS is 583.51 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025583.51
Mar2024-91.80
Mar20235.46
Mar202223.93
Mar2021404.51

How is EBIT Growth of BALAXI PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 583.51
Positive
Mar2024 -91.8
Negative
Mar2023 5.46
-77.18
Mar2022 23.93
-94.08
Mar2021 404.51 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EBIT Growth ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹110.0 Cr -0.9% -18.3% -63.2% Stock Analytics
ADANI ENTERPRISES ₹286,323.0 Cr 2.5% 9.8% 5.7% Stock Analytics
REDINGTON ₹19,122.2 Cr -2.7% -6.9% -2.8% Stock Analytics
HONASA CONSUMER ₹9,997.0 Cr 1.9% 14.5% 33.6% Stock Analytics
MMTC ₹9,225.0 Cr -1% -10.9% 8.1% Stock Analytics
LLOYDS ENTERPRISES ₹8,133.5 Cr -3.3% -8.5% 16% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.9%

-18.3%

-63.2%

SENSEX

-0.3%

-0.1%

8.3%


You may also like the below Video Courses